Product NDC: | 0430-3030 |
Proprietary Name: | Dovonex |
Non Proprietary Name: | Calcipotriene |
Active Ingredient(s): | .05 mg/mL & nbsp; Calcipotriene |
Administration Route(s): | TOPICAL |
Dosage Form(s): | SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0430-3030 |
Labeler Name: | Warner Chilcott (US), LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | NDA020611 |
Marketing Category: | NDA |
Start Marketing Date: | 20060101 |
Package NDC: | 0430-3030-95 |
Package Description: | 25 CARTON in 1 CASE (0430-3030-95) > 6 BOTTLE in 1 CARTON > 8 mL in 1 BOTTLE |
NDC Code | 0430-3030-95 |
Proprietary Name | Dovonex |
Package Description | 25 CARTON in 1 CASE (0430-3030-95) > 6 BOTTLE in 1 CARTON > 8 mL in 1 BOTTLE |
Product NDC | 0430-3030 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Calcipotriene |
Dosage Form Name | SOLUTION |
Route Name | TOPICAL |
Start Marketing Date | 20060101 |
Marketing Category Name | NDA |
Labeler Name | Warner Chilcott (US), LLC |
Substance Name | CALCIPOTRIENE |
Strength Number | .05 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Vitamin D [Chemical/Ingredient],Vitamin D Analog [EPC] |